Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Noriaki Kyogoku"'
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:575-579
Autor:
Yuma Ebihara, Noriaki Kyogoku, Yoshihiro Murakami, Katsuhiko Murakawa, Fumitaka Nakamura, Takayuki Morita, Shunichi Okushiba, Satoshi Hirano
Publikováno v:
Updates in surgery.
This study aimed to investigate the incidence and prognosis of postoperative complications after laparoscopic total gastrectomy (LTG) for gastric cancer (GC). We retrospectively enrolled 411 patients who underwent curative LTG for GC at seven institu
Autor:
Toshiaki Shichinohe, Takayuki Morita, Shunichi Okushiba, Katsuhiko Murakawa, Yuma Ebihara, Fumitaka Nakamura, Noriaki Kyogoku, Satoshi Hirano
Publikováno v:
Langenbeck's Archives of Surgery. 403:463-471
Purpose: We used propensity score matching to compare the complication rates after laparoscopic total gastrectomy (LTG) with esophagojejunostomy (EJS) performed using a circular or a linear stapler. Methods: We retrospectively enrolled all patients w
Autor:
NORIAKI KYOGOKU1 bigmuff118@yahoo.co.jp, HIROAKI IKEDA2, TAKAHIRO TSUCHIKAWA1, TAKEHIRO ABIKO1, AKI FUJIWARA1, TAKEHIRO MAKI1, YOSHIYUKI YAMAMURA1, MASAOMI ICHINOKAWA1, KIMITAKA TANAKA1, NAOKO IMAI2, YOSHIHIRO MIYAHARA2, SHINICHI KAGEYAMA2, HIROSHI SHIKU2, SATOSHI HIRANO1
Publikováno v:
Oncology Letters. Dec2016, Vol. 12 Issue 6, p4493-4504. 12p.
Autor:
Yoshihiro Matsuno, Kichizo Kaga, Takehiro Maki, Eiichi Tanaka, Yukiko Tabata, Takahiro Tsuchikawa, Kanako C. Hatanaka, Takehiro Abiko, Toshiaki Shichinohe, Yoshiyuki Yamamura, Hiroaki Ikeda, Naoko Imai, Noriaki Kyogoku, Satoshi Hirano, Aki Kuroda, Yasuhiro Hida
Publikováno v:
International Journal of Oncology. 50:129-140
Wilms tumor 1 (WT1) is considered to be a promising target of cancer treatment because it has been reported to be frequently expressed at high levels in various malignancies. Although WT1-targeted cancer treatment has been initiated, conclusive detec
Autor:
Takehiro Maki, Takahiro Tsuchikawa, Kimitaka Tanaka, Masaomi Ichinokawa, Hiroshi Shiku, Yoshiyuki Yamamura, Aki Fujiwara, Takehiro Abiko, Shinichi Kageyama, Hiroaki Ikeda, Noriaki Kyogoku, Satoshi Hirano, Yoshihiro Miyahara, Naoko Imai
Publikováno v:
Oncology Letters
A phase I+II clinical trial of vaccination with MAGE-A4 protein complexed with cholesteryl pullulan melanoma antigen gene-A4 nanogel (CHP-MAGE-A4) is currently underway in patients with MAGE-A4-expressing cancer. In the present study, the primary pha
Autor:
Shinichi Kageyama, Toshiaki Shichinohe, Takahiro Tsuchikawa, Kengo Miyauchi, Hiroshi Shiku, Hiroaki Ikeda, Noriaki Kyogoku, Satoshi Hirano, Yoshihiro Miyahara, Takehiro Abiko, Masataka Wada
Publikováno v:
Immunotherapy. 8:527-540
Aim: To investigate the antigen spreading pattern in the CHP-MAGE-A4-vaccinated patients and analyze the clinical relevance of antigen spreading pattern as a surrogate marker of patient survival. Materials & methods: 12 patients who had been injected
Autor:
Toshihiko Kuwatani, Takahiro Tsuchikawa, Toshiaki Shichinohe, Kengo Miyauchi, Hiroshi Shiku, Yoshihiro Miyahara, Masataka Wada, Shinichi Kageyama, Takehiro Abiko, Noriaki Kyogoku, Satoshi Hirano, Shintaro Takeuchi, Hiroaki Ikeda
Publikováno v:
Anticancer Research. 38
Background/aim The aim of this study was to explore whether the treatment effect or immune response to a cancer vaccine can be predicted by the percentage of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in peripheral blood mononuclear cells (PBMCs) aft
Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status
Autor:
Takehiro Noji, Kimitaka Tanaka, Yasuhiro Hida, Hiroaki Ikeda, Aki Fujiwara-Kuroda, Hiroshi Shiku, Yoshiro Matsui, Noriaki Kyogoku, Takehiro Abiko, Tatsuya Kato, Kichizo Kaga, Satoshi Hirano, Shinichi Kageyama, Masaomi Ichinokawa, Takahiro Tsuchikawa
Publikováno v:
International journal of oncology. 53(2)
Melanoma antigen family A4 (MAGEA4), a cancer/testis antigen, is overexpressed and is thus an immunotherapy target in various malignant tumors, including non-small cell lung cancer. However, whether MAGEA4 induces or inhibits the apoptosis of lung ca
Autor:
Toshiaki Shichinohe, Masataka Wada, Yoshiyuki Yamamura, Noriaki Kyogoku, Satoshi Hirano, Toshihiko Kuwatani, Takehiro Maki, Aki Kuroda, Shintaro Takeuchi, Kengo Miyauchi, Takahiro Tsuchikawa
Publikováno v:
International Journal of Clinical Oncology. 20:386-394
It has recently been shown that certain chemotherapeutic agents can improve host immune responses. The present study aimed to demonstrate the mechanism by which chemotherapeutic agents modify the tumor microenvironment and induce tumor-specific immun